Navigating analytical irregularities with independent testing

22nd Nov 2023

Pharmaceutical organisations require precise, reproducible analytical results as their API progresses through development and manufacturing. Sometimes, unanticipated discrepancies in stability, product yield and other key areas can arise when performing later stage testing.

Click below to read more.

Download resource

Related Content

Overcoming genotoxic impurities through a robust analytical approach

Setting the foundation for success: Streamlining early phase API discovery and development

Cary, North Carolina, US